Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
N. Cobanoglu, U. Ozcelik, U. Kalyoncu, S. Ozen, S. Kiraz, N. Gurcan, M. Kaplan, D. Dogru, E. Yalcin, S. Pekcan, M. Kose, R. Topaloglu, N. Besbas, A. Bakkaloglu, N. Kiper (Ankara, Turkey). Using an interferon-γ assay for the diagnosis of tuberculosis infection before using tumor necrosis factor-α blockers. Eur Respir J 2007; 30: Suppl. 51, 254

Member's Comments

No comment yet.

Related content which might interest you: Screening for latent tuberculosis before tumour necrosis factor antagonist therapy Source: Eur Respir J 2015; 45: 1512-1513 Year: 2015 Screening for latent tuberculosis before tumour necrosis factor antagonist therapy Source: Eur Respir J 2015; 45: 1510-1512 Year: 2015 Screening and monitoring of tuberculosis in patients on tumor necrosis factor antagonist therapy Source: Annual Congress 2011 - Clinical challenges in tuberculosis Year: 2011 Re-activation of bovine tuberculosis in a patient treated with infliximab Source: Eur Respir J 2008; 32: 229-231 Year: 2008 Tumor necrosis factor alpha inhibitors and reactivation of tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 281s Year: 2007 Isoniazid protection and risk of tuberculosis in patients who used anti tumor necrosis factor-alpha treatment Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease Year: 2007 The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement Source: Eur Respir J 2010; 36: 1185-1206 Year: 2010 QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases Source: Eur Respir J 2009; 33: 586-593 Year: 2009 Interferon-? release assays for the diagnosis of latent Mycobacterium tuberculosis infection Source: Eur Respir J 2011; 38: 1238-1239 Year: 2011 Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection Source: Eur Respir J 2011; 38: 1237-1238 Year: 2011 The risk of tuberculosis related to tumour necrosis factor antagonist therapies Source: Annual Congress 2011 - TBNET: tuberculosis research in Europe Year: 2011 A screening for latent tuberculosis infection among candidates to anti-tumor necrosis factor-alpha agents using a whole blood interferon-gamma test Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease Year: 2008 The levels of tumour necrosis factor-alpha and interleukin-1 in newly diagnosed and multi drug resistant tuberculosis Source: Annual Congress 2004 - Clinical and diagnostic features of tuberculosis Year: 2004 Interferon gamma assays in the diagnosis of TB pleuritis Source: Annual Congress 2006 - Immunology of tuberculosis and diagnosis of tuberculosis infection Year: 2006 The use of tumor necrosis factor alpha inhibitor pentoxifylline in the treatment of patients with I and II stages of pulmonary sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 542s Year: 2006 Pulmonary infections in patients receiving treatment of tumor necrosis factor alpha antagonists Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Follow up results of patients receiving anti tumor necrosis antagonists and evaluation of risk of tuberculosis Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009 Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis Source: Eur Respir J 2007; 30: 321-332 Year: 2007 Update: T-cell interferon-gamma release assays for the diagnosis of MTB infection Source: Annual Congress 2008 - PG20 - Advances in the diagnosis of Mycobacterium tuberculosis infection: an interactive, case-based course Year: 2008 An evaluation of the use of a negative interferon gamma release assay for tuberculosis screening before TNF antagonist therapy Source: Eur Respir J 2014; 44: 1369-1372 Year: 2014